Organoids and regenerative hepatology
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The burden of liver diseases is increasing worldwide, with liver transplantation remaining the only treatment option for end‐stage liver disease. Regenerative medicine holds great potential as a therapeutic alternative, aiming to repair or replace damaged liver tissue with healthy functional cells. The properties of the cells used are critical for the efficacy of this approach. The advent of liver organoids has not only offered new insights into human physiology and pathophysiology, but also provided an optimal source of cells for regenerative medicine and translational applications. Here, we discuss various historical aspects of 3D organoid culture, how it has been applied to the hepatobiliary system, and how organoid technology intersects with the emerging global field of liver regenerative medicine. We outline the hepatocyte, cholangiocyte, and nonparenchymal organoids systems available and discuss their advantages and limitations for regenerative medicine as well as future directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 5×
“These ‘mini‐livers’ have been primarily transplanted ectopically in the cranium, in the mesentery or under the splenic capsule rescuing animal models of drug‐induced liver failure.[51,52] So far, only iPSC‐based multicellular organoids have been developed, which exhibit similar advantages and limitations to iPSC‐deriv…”
BackgroundMethodInfluentialLong-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M. M. A., Ellis, E., van Wenum, M., Fuchs, S. A., de Ligt, J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.050 · Cited by 1,619
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Huch, M., Dorrell, C., Boj, S. F., van Es, J. H., Li, V. S. W., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M. J., et al. (2013) · Nature · doi:10.1038/nature11826 · Cited by 1,555 · cited 2×
“established the self‐renewing, genetically stable, long‐ term expansion of adult murine‐derived liver organoid cultures.[47] This was achieved by combining Matrigel with hepatocyte growth factor, epidermal growth factor, fibroblast growth factor (FGF), and R‐Spondin (RSPO1) with the isolated liver cells.”
BackgroundMethodEiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., & Sasai, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.002 · Cited by 1,522 · cited 1×
“cells using 3D aggregate culture.[33] Then, in 2009, Sato et al.”
MethodHuman primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471 · cited 2×
“[53–55] Moreover, patient‐derived organoid cultures have also been exploited to create disease models for Alagille syndrome,[48] alpha‐1‐antitrypisn (A1AT) deficiency,[48] polycystic liver disease,[56] as well as cancer.[57] Even with all the above‐mentioned multicellular organoids, none had contained the biliary stru…”
BackgroundDesigner matrices for intestinal stem cell and organoid culture
Gjorevski, N., Sachs, N., Manfrin, A., Giger, S., Bragina, M. E., Ordóñez-Morán, P., Clevers, H., & Lutolf, M. P. (2016) · Nature · doi:10.1038/nature20168 · Cited by 1,426
3D Cell Culture Systems: Advantages and Applications
Ravi, M., Paramesh, V., Kaviya, S. R., Anuradha, E., & Solomon, F. D. P. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24683 · Cited by 1,206 · cited 1×
“[26–28] Subsequently, various 3‐ dimensional (3D) cell culture systems were developed and have been in active use for many decades, including the hanging drop method,[29] embryoid body formation,[29] and cultures embedded in, or grown upon, extracellular matrix (ECM).[30] Late in the 20th century, scientists began to…”
BackgroundHofer, M., & Lutolf, M. P. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00279-y · Cited by 1,184
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Cited by
Human liver organoids: From generation to applications
Afonso, M. B., Marques, V., van Mil, S. W. C., & Rodrigues, C. M. P. (2024) · Hepatology · doi:10.1097/hep.0000000000000343 · Cited by 61
Developing Liver Microphysiological Systems for Biomedical Applications
Wang, J., Wu, X., Zhao, J., Ren, H., & Zhao, Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302217 · Cited by 27
3D bioprinting lobule-like hepatorganoids with induced vascularization for orthotopic implantation
Yan, J., Ye, Z., Lu, Y., Yuan, Y., Wang, X., Yan, T., Yin, J., & Wang, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101515 · Cited by 15
Cell therapy for end-stage liver disease: Current state and clinical challenge
Zhang, L., Deng, Y., Bai, X., Wei, X., Ren, Y., Chen, S., & Deng, H. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003332 · Cited by 12
“[54] 57] Although the use of cells induced from PSCs for transplantation will encounter practical issues, including tumorigenicity, immunogenicity, and heterogeneity, [58] researchers continue to try to overcome these hurdles and have achieved some success, such as liver organoids and…”
Metadata
- Authors
- Jalan‐Sakrikar, N., Brevini, T., Huebert, R. C., & Sampaziotis, F.
- Venue
- Hepatology
- Published
- 2022-06-23
- Volume
- 77
- Issue
- 1
- Pages
- 305-322
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4281254964
- Cited by
- 49
- References
- 41
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Organoids and regenerative hepatology. https://app.cochat.ai/papers/10.1002/hep.32583
- The paper
- Jalan‐Sakrikar, N., Brevini, T., Huebert, R. C., & Sampaziotis, F. (2023). Organoids and regenerative hepatology. Hepatology. https://doi.org/10.1002/hep.32583
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.